Coming Soon…

What is NIMA™?

NIMA is an innovative non-invasive metabolic test designed to identify euploid embryos. The combination of mass spectrometry (MASS SPEC) and machine learning for analyzing complex metabolic profiles is a promising approach in reproductive medicine.

Key Points About NIMA™

  • Non-Invasive: NIMA™ is non-invasive, which means it doesn’t require invasive procedures to assess embryos.
  • Metabolic Analysis: It focuses on metabolic profiling, which can provide valuable information about the health and viability of embryos.
  • Accuracy: NIMA™ has demonstrated a 90% accuracy rate during its initial validation, which suggests it could be a reliable tool for embryo selection.
  • Versatility: NIMA™ can be used either on its own or in combination with other technologies like niPGTA (non-invasive preimplantation genetic testing for aneuploidy) and artificial intelligence (AI).

If individuals are interested in learning more about the NIMA™ research project or wish to participate, they should contact your clinic team. This research could potentially have a significant impact on improving the success rates of assisted reproductive techniques.